FDA authorizes Regeneron's Covid treatment, taken by Trump, for emergency use
November 21, 2020 at 20:36 PM EST
Regeneron's therapy is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight infections.